Even if the pain is mild or hard on the brain

Published Date: 08 Mar 2023

A new study shows structural and functional changes in the brain associated with anxiety and depression after mild COVID-19 infection.

Read Full News

Latest News

A Blood Test for Colon Cancer Screening? Not So Fast!

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

Both Sides of the Bars: Jail Reform as Mental Health Policy

Jails have become de facto psychiatric institutions. Dr Temitope Ogundare explains why psychiatrists should help prevent incarceration — not just treat its consequences.

All Quiet on the Vaccine Front?

While public support for vaccines remains strong, quieter efforts to weaken vaccine policy, compensation programs, and scientific oversight are gaining ground. Here's what physicians need to know.

To Treat or Not to Treat? The COVID Conundrum

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

The Challenge With Health Data Is Using It Well

An international survey finds physicians are ready to use wearable health data. The bigger challenge is building the systems to turn that information into better care.

Sickle Cell Disease Linked to Higher Postpartum LARC Use

People with sickle cell disease received immediate postpartum long-acting reversible contraception at more than three times the rate of those without the condition, even after adjusting for clinical and demographic factors.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

Dr Aasma Shaukat says that the convenience of a blood test for colorectal cancer should not outweigh the performance of a blood test, especially when weighed against the other options available.

Jails have become de facto psychiatric institutions. Dr Temitope Ogundare explains why psychiatrists should help prevent incarceration — not just treat its consequences.

While public support for vaccines remains strong, quieter efforts to weaken vaccine policy, compensation programs, and scientific oversight are gaining ground. Here's what physicians need to know.

A 31-year-old presents with COVID and wants medication to fight the infection. Dr Chuck Vega weighs in on the evidence for standard-risk patients.

An international survey finds physicians are ready to use wearable health data. The bigger challenge is building the systems to turn that information into better care.

People with sickle cell disease received immediate postpartum long-acting reversible contraception at more than three times the rate of those without the condition, even after adjusting for clinical and demographic factors.

News All Time

Focal Therapy Shows Favorable Long-Term Outcomes

A large registry study finds low 10-year prostate cancer mortality after focal HIFU or cryotherapy, but experts caution randomized comparisons with standard treatments are needed.

Blood Test Flags Gynaecologic Cancer Risk in NHS Trial

A blood test correctly flags 99% of gynaecologic cancers as high risk in the largest NHS AI triage trial yet.

Parental Anxiety Persists Up to 2 Years After NICU Discharge

Parents of extremely premature infants show higher anxiety levels well beyond hospital discharge.

Noncardia Gastric Cancer Risk Higher in Some Ethnic Groups

Hispanic and Asian populations in the US show a clinically meaningful risk for noncardia gastric cancer up to two decades earlier than non-Hispanic White populations.

Holmium Enucleation Safe for Recurrent Prostatic Obstruction

Holmium laser enucleation of the prostate appears safe and effective for patients who have recurrent benign prostatic obstruction.

High Suspicion for Cyclosporiasis Needed, Tracing Continues

With the outlines shifting in the current outbreak, testing for the parasite is a no-brainer, say experts.

Fecal Biomarkers Distinguish Pediatric IBD From Diarrhea

Fecal eosinophil-derived neurotoxin, lipocalin-2, and calprotectin are elevated in pediatric IBD, with calprotectin best distinguishing IBD from acute diarrhea, a recent study shows.

First Evidence That Targeting Tau May Slow Cognitive Decline

The investigational drug diranersen led to tau reduction with the lowest dose showing the most consistently positive clinical effect.

Health Disparities and Access Barriers in GAD Care

Matthew Macaluso, DO, comments on systemic barriers that delay GAD diagnosis, highlighting the need for better access to psychiatric care and integrated treatment pathways.

Lecanemab for AD Shows Sustained Benefit in Real-World Study

Real-world data suggest lecanemab’s safety and efficacy mirror results from the pivotal Clarity AD trial and highlight the growing use of blood-based biomarkers in clinical practice.

Chemo Tied to Longer Survival After Pelvic Exenteration

A retrospective international study suggests adjuvant chemotherapy is associated with longer survival after pelvic exenteration in patients with high-risk gynecologic cancers.

When the Algorithm Knows the Risk but Misses the Fear

AI may flag low clinical risk, but it can still miss the patient’s fear, story, and lived experience.

THC-CBD Combination Reduces Agitation in Advanced Dementia

In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.

Adults Maltreated During Childhood Face Higher Disease Risk

Abuse or neglect during childhood is associated with increased risks for chronic physical and mental health conditions during adulthood, a study finds.

Freezing of Gait in Parkinson’s: What’s Beyond Medication?

A conference review highlights how combining cognitive, motor, and sensory training with cueing strategies may improve freezing of gait in Parkinson’s disease.

What the Fourth Year of Med School Is Really Like

Fourth-year med students are in for a lot of stress, anxiety, and expense, just not from studying.

Recommended News For You

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again

Are ultramarathon runners really at increased risk of bowel cancer?

The Effect of Common Steroids on Cancer Treatments.

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

WHO launches plan for free child cancer medicines

Recommended Articles For You

Precision Oncology: Personalized Medicine Shaping the Future of Cancer Care 

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer 

Unmasking the Hidden Symptoms of Ovarian Cancer 

Tumor Microenvironment Reprogramming Through Stromal Modulation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The hidden costs of cancer for young survivors are derailing their financial futures

2.

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

1.

The Benefits of Understanding Haptoglobin High: What You Need to Know

2.

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy 

3.

Hypercoagulable State: Factors that Contribute to Blood Clots 

4.

Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use

5.

Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

5.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot